In addition, ZVI@CMC could serve as a DNMT inhibitor to restore SOX17/NRF2 axis, and the combination of ZVI@CMC with radiation treatment significantly augmented anticancer efficacy to inhibit the tumor growth of CCRT resistant cancer. Here, SOX17 is linked to neoplasm.